4//SEC Filing
Spangler Patrick D 4
Accession 0001296525-25-000002
CIK 0001448431other
Filed
Sep 10, 8:00 PM ET
Accepted
Sep 11, 1:55 PM ET
Size
5.4 KB
Accession
0001296525-25-000002
Insider Transaction Report
Form 4
OptimizeRx CorpOPRX
Spangler Patrick D
Director
Transactions
- Sale
Common Stock
2025-08-28$17.49/sh−11,120$194,489→ 44,215 total
Footnotes (1)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.47 through $18.43. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, complete information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
Documents
Issuer
OptimizeRx Corp
CIK 0001448431
Entity typeother
Related Parties
1- filerCIK 0001296525
Filing Metadata
- Form type
- 4
- Filed
- Sep 10, 8:00 PM ET
- Accepted
- Sep 11, 1:55 PM ET
- Size
- 5.4 KB